Skip to main content

Table 1 Use of antimicrobial agents in children with suspected systemic infection

From: Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study

 

Number of children (%) receiving drug

Age of child on blood culture

0–6 days

7–30 days

1 month – 7 years

Total

No of patients

n = 261

n = 190

n = 1106

n = 1557

Any antibacterial

257 (98.5)

186 (97.9)

1017 (92.0)

1460 (93.8)

- Penicillin

-

-

301 (27.2)

301 (19.3)

- Ampicillin/amoxicillin

244 (93.5)

165 (86.8)

589 (53.3)

998 (64.1)

- Cloxacillin

244 (93.5)

165 (86.8)

354 (32.0)

763 (49.0)

- Cephalexin

-

-

27 (2.4)

27 (1.7)

- Cefuroxime

-

-

37 (3.3)

37 (2.4)

- Ceftriaxone

34 (13.0)

51 (26.8)

118 (10.7)

203 (13.0)

- Chloramphenicol

-

2 (1.1)

416 (37.6)

418 (26.8)

- Gentamicin

250 (95.8)

173 (91.1)

504 (45.6)

927 (59.5)

- Amikacin

-

1 (0.5)

25 (2.3)

26 (1.7)

- Co-trimoxazole

-

3 (1.6)

129 (11.7)

132 (8.5)

- Erythromycin

-

2 (1.1)

44 (4.0)

46 (3.0)

- Azithromycin

-

-

23 (2.1)

23 (1.5)

- Nalidixic acid

-

-

4 (0.4)

4 (0.3)

- Metronidazole

-

-

22 (2.0)

22 (1.4)

TB medicines

-

-

71(6.4)

71(4.6)

Any antimalarial

19(7.3)

23 (12.1)

784 (70.9)

826 (53.1)

- Quinine

6 (2.3)

16 (8.4)

636 (57.5)

658 (42.3)

- Sulfadoxine-pyrimethamine

-

1 (0.5)

192 (17.4)

193 (12.4)

- Chloroquine

15 (5.7)

9 (4.7)

7 (0.6)

31 (2.0)

- Amodiaquine

-

-

12 (1.1)

12 (0.8)

- Artesunate

-

-

1 (0.1)

1 (0.1)

Mebendazole

-

-

44(4.0)

44(2.8)

Nystatin (oral)

8(3.1)

13(6.8)

195 (17.6)

216 (13.9)

Systemic antifungal

-

-

8(0.7)

8(0.5)